Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

- PMLiVE

The global antibiotic crisis: a 2020 perspective

A report from the CDC says the ‘approaching’ post-antibiotic era is already here

- PMLiVE

UK contributes £210m towards COVID-19 vaccine efforts

Prime Minister Boris Johnson also tests positive for coronavirus

- PMLiVE

Bluebird bio pushes back commercial launch of Zynteglo due to COVID-19

First patient is likely to be treated later in the year due to pandemic

- PMLiVE

In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa

Monthly meeting held remotely for the first time due to COVID-19 pandemic

- PMLiVE

COVID-19 delays Pfizer, Mylan’s generics merger and spin-out

Fallout from pandemic continues to affect business in myriad ways

COVID-19 message to clients from OPEN Health CEO, David Rowley

Dear OPEN Health Clients,I want to highlight to our clients what we’re doing in response to the Coronavirus outbreak to protect our staff, our clients and the community.We’re following the...

OPEN Health

- PMLiVE

The march to sustainability

How sustainability can be achieved within the pharma sector and the critically important role of the communicator

- PMLiVE

The Lucid Group Thirsty Thursday: What’s in a story?

Yes, it’s that time of the month, a time everyone at Lucid has come to love and anticipate. Whether it’s sharing best practice, learning about new skills, gathering insights or...

Lucid Group Communications Limited

- PMLiVE

Novartis forms coronavirus alliance with life sciences companies

Partnership will accelerate research with aid of Gates Foundation

- PMLiVE

Immutep slumps on latest efti data in breast cancer

Drug was unable to improve progression-free survival compared to placebo

- PMLiVE

Dan Russell joins Seven Stones as managing director

Joins the team to help drive global expansion

- PMLiVE

BMS suspends new clinical trials as COVID-19 cases rise in US

Existing sites can continue to recruit new subjects

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links